reference/8855883

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8855883

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	11834
issn	1477-9226 1477-9234
issueIdentifier	34
pageRange	11828-11834
publicationName	Dalton transactions (Cambridge, England : 2003)
startingPage	11828
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ea1f6a20f439e2cb5f199ead34f0f22d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cbe5d72eb743bb81feba3f0841471156 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b62538f9fad9fdb20d77eef6e3d150c5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0d68bd24d05625bc3bab64441dc6d61c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4282406d51c358fc288092ac5d86933e
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fa123dddeb1c49440e2255e61d78b502
bibliographicCitation	Gandioso A, Rovira A, Shi H, Sadler PJ, Marchán V. Unexpected photoactivation pathways in a folate-receptor-targeted trans-diazido Pt(IV) anticancer pro-drug. Dalton Trans. 2020 Sep 01;49(34):11828–34. doi: 10.1039/d0dt02577a. PMID: 32815971.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2c57cc8063f90905a684ff825d57074 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e29d203b5feff97c4c01f4862d6f4aa8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_609eb0d556f9755343ae3c6f50346f04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1905-2156 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9160-1941
date	2020-09-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1039/d0dt02577a https://pubmed.ncbi.nlm.nih.gov/32815971
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/31991 https://portal.issn.org/resource/ISSN/1477-9234 https://portal.issn.org/resource/ISSN/1477-9226
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Unexpected photoactivation pathways in a folate-receptor-targeted trans-diazido Pt(iv) anticancer pro-drug
discusses	http://id.nlm.nih.gov/mesh/M0545592 http://id.nlm.nih.gov/mesh/M0015422 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0002074 http://id.nlm.nih.gov/mesh/M0017642
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008027 http://id.nlm.nih.gov/mesh/D058973Q000378 http://id.nlm.nih.gov/mesh/D011355Q000378 http://id.nlm.nih.gov/mesh/D009944Q000737 http://id.nlm.nih.gov/mesh/D009944Q000494 http://id.nlm.nih.gov/mesh/D058990 http://id.nlm.nih.gov/mesh/D001386Q000737
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009944Q000378 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000970Q000378 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D000970Q000737 http://id.nlm.nih.gov/mesh/D061986
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4876 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398660 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135409352 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398634

Showing number of triples: 1 to 55 of 55.